This presentation by the European Medicines Agency on Covid-19 drug testing monitoring.
Most of us know that medicines carry risks as well as rewards, but just how are they monitored?
This presentation by the European Medicines Agency does a fantastic job of explaining, in a straightforward way, how the safety of new covid19 drugs are monitored and recorded throughout each step of the drugdevelopment process.
Providing a full suite of pharmaceutical services for over two decades, QUINTA-ANALYTICA are market-leaders in drug testing, clinical studies, bioanalytical services & more.
Get in toush with us today to discuss how we can help support you.
18 July 2023
Challenges of a large-scale study of breast cancer
Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.
29 June 2023
EU funding for Quinta-Analytica laboratory in Brno (CZ) was succesfully completed.
After two years, the project to finance new equipment for the Quinta-Analytica laboratory in Brno was successfully completed. The investment from European Regional Development Fund was used in this project.
22 June 2023
Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies
EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency